Newly released 2014 Cancer Progress Report from the American Association for Cancer Research highlights the need for increased federal funding of cancer research.
1 in 10 patients with cancer would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria.
A retrospective study identifies a potential link between NSAID use and breast cancer recurrence and overweight and obese women.
Immunotherapeutic approaches to treating cancer have been evaluated during the last few decades with limited success.
Although ADT remains an important treatment, its use as primary therapy in low-risk prostate cancer seems increasingly ill advised.
Biomarkers can provide great opportunities in the management of the most common HIV-associated malignancies, namely, Kaposi sarcoma, non-Hodgkin's lymphoma, and invasive cervical cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|